2024-02-28 2024-02-28 , online online, 890 € zzgl. MwSt. Dr Roisin Adams https://www.forum-institut.de/seminar/24032002-eu-hta-national-preparation-and-the-work-of-the-hta-coordination-group/referenten/24/24_03/24032002-eu-hta-national-preparation-and-the-work-of-the-hta-coordination-group_adams-roisin.jpg EU HTA: National preparation and the work of the HTA coordination group

This webcast combines the work of the HTA coordination group with the national preparation for the EU-HTA in the Nordic countries, Austria and Ireland.

Topics
  • Keynote: Update on the work of the HTA coordination group
  • EU HTA: Alignment with national HTA processes in the Nordic countries, Austria and Ireland
  • Potential impact of JCA on timelines and securing reimbursement of new medicines


Who should attend
This webcast is aimed at specialists and managers in the pharmaceutical industry who bring new medicinal products to market. In particular, staff from the clinical development, outcomes research and market access departments will gain valuable information on study planning and future market access preparations.
Aims and objectives
This webcast focuses on the national preparation for the EU HTA in the Nordic countries, Austria and Ireland. Our experts will provide the latest information on national procedures during the transition period and country-specific preparations for the EU HTA. They will also provide firsthand insights into the work of the HTA coordination group.
Your benefit

  • Local experts provide insights into national HTA procedures during the transition period
  • Firsthand information about the work of the HTA coordination group
This webcast combines the work of the HTA coordination group with the national preparation for the EU HTA in the Nordic countries, Austria and Ireland.

24032002 Seminar EU HTA: National preparation and the work of the HTA coordination group

EU HTA: National preparation and the work of the HTA coordination group

Benefits
  • Update on the work of the HTA coordination group
  • EU HTA: Alignment with national HTA processes
  • Focus: Nordic countries, Austria, Ireland

Webcode 24032002

Jetzt buchen

JETZT Buchen

Referenten


Alles auf einen Blick

Termin

26/03/2024

26/03/2024

Zeitraum

10:00 - 15:00
You may dial in 30 minutes in advance

10:00 - 15:00
You may dial in 30 minutes in advance
Veranstaltungsort

online

online

Gebühr
Your contact

Dr. Henriette Wolf-Klein
Head of Department

+49 6221 500-680
h.wolf-klein@forum-institut.de

Details

This webcast combines the work of the HTA coordination group with the national preparation for the EU-HTA in the Nordic countries, Austria and Ireland.

Topics

  • Keynote: Update on the work of the HTA coordination group
  • EU HTA: Alignment with national HTA processes in the Nordic countries, Austria and Ireland
  • Potential impact of JCA on timelines and securing reimbursement of new medicines


Who should attend
This webcast is aimed at specialists and managers in the pharmaceutical industry who bring new medicinal products to market. In particular, staff from the clinical development, outcomes research and market access departments will gain valuable information on study planning and future market access preparations.

Aims and objectives

This webcast focuses on the national preparation for the EU HTA in the Nordic countries, Austria and Ireland. Our experts will provide the latest information on national procedures during the transition period and country-specific preparations for the EU HTA. They will also provide firsthand insights into the work of the HTA coordination group.

Your benefit

  • Local experts provide insights into national HTA procedures during the transition period
  • Firsthand information about the work of the HTA coordination group
This webcast combines the work of the HTA coordination group with the national preparation for the EU HTA in the Nordic countries, Austria and Ireland.

Detailed programme

10:00 - 15:00
You may dial in 30 minutes in advance

10:00

Dr Thomas Ecker

Opening address

10:30

Dr Roisin Adams

Keynote: Update on the work of the HTA coordination group

11:15 Time for discussion


11:30 Coffee break


11:45

Anne Dano

EU HTA: Alignment with national HTA processes in the Nordic countries
  • National scientific consultation on the HTA
  • Consequences of EU HTAs for national reimbursement procedures
  • The EU HTA and national access programmes
  • Participation in or experience with JSC

12:30

Barbara Moeller

EU HTA: Alignment with national HTA processes in Austria
  • Overview of reimbursement procedures for new active ingredients in Austria
  • Potential need for adjustment
  • Statur or (expected) (time) plan for the adjustment

13:15 Lunch break


14:15

Sandra Redmond

EU HTA: Alignment with national HTA processes in Ireland
  • Brief overview of reimbursement procedures for new active ingredients in Ireland
  • Potential need for adjustment
  • Status or (expected) (time) plan of the adjustment
  • Potential impact of JCA on timelines and securing reimbursement of new medicines

15:00

Dr Thomas Ecker

Final remarks

Further information

Attend the whole webcast series

This webcast is part of a webcast series which already started in August 2023. The upcoming webcasts are: Part 3: 13 December 2023: We will focus on the national requirements in France, Spain and Italy in the transition period, and also look at the requirements in the UK (in English). Part 4: 26 March 2024: We will focus on the work of the HTA coordination group and on the national requirements in the Nordic countries, Austria and Ireland (in English).. Part 5: 15 May 2024: We will focus on dossier preparation and joint scientific consultations (in German). The whole webcast series can be found here: EU-HTA-Webcastreihe: immer up to date bis 2025!

This distinguishes our events

Overall score of all evaluations in 2023

Five stars on Trustpilot = Excellent

Recommendations

Outcomes Research-Lehrgang

Health Economics, Outcomes Research, Beobachtungsstudien, Digitalisierung - hier vertiefen Sie Ihr Know-how zur evidenzb...

20. - 21.03.2024, Online
Details

EU-Zulassung für Einsteiger

In diesem Seminar erhalten Sie Know-how zur Zulassung von Arzneimitteln in Europa. Sie lernen, welche Zulassungswege mög...

16. - 19.04.2024, Online
Details

Crashkurs Pharma Business Development

Crashkurs Pharma Business Development - für Neu- und Quereinsteiger*innen

12. - 13.03.2024, Online
Details

Grundlagen für Regulatory Affairs von Medizinprodukten

Das kompakte Basisseminar: Lernen Sie die Grundbegriffe und Essentials für Regulatory Affairs von Medizinprodukte kennen...

06. - 07.03.2024, Online
Details

Internationale Medizinprodukte-Zulassung

Der Online-Kurs gibt Ihnen einen Überblick über die Zulassung von Medizinprodukten in wichtigen Weltmärkten: Regulatoris...

21. - 22.03.2024, Online
Details

Go forward

Our international course portfolio

Are you interested in our international continuous education programme? We provide a variety of specialised courses.

Details
Our international course portfolio
Testimonials

Hear from our past delegates and sponsors and learn more about the events.

Details
Testimonials
Cooperation Partners

We team up with other companies and experts to fulfill projects worldwide.

Details
Cooperation Partners